Uveal Melanoma Market: Emerging Trends & Upcoming Pharmaceutical Research Date: 03-01-2017 12:10 AM CET Category: Health & Medicine Press release from: Transparency Market Research - Pharmaceutical
Global Uveal Melanom Market: Overview Uvea is present posterior to sclera and the cornea and has three parts namely, iris, ciliary body and choroid. Uveal melanoma is referred as the cancer of the parts of eye including the iris choroid and ciliray body. It is the condition in which the tumors arise from the melanocytes residing within the uva responsible for the color of the eye. Though is a rare condition, it is most common type of intraocular malignancy in adults. The uveal melanoma treatment depends on various factors most important being the size of the tumor. This type of melanoma is completely asymptomatic in the initial stages. On enlargement of tumor with time, certain changes may be observed such as distortion of pupil, decreased visibility due to secondary retinal detachment and blurred vision. Risk factors for this kind of cancer include fair complexion, blue, and green or light colored eyes, and older age. The role of inherited genetic mutation in uveal melanoma is yet unknown. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. The society also reports about 2,730 new cases in 2014 of uveal melanoma in the U.S. Browse Global Strategic Business Report: www.transparencymarketresearch.com/uveal-melanoma-market.... Global Uveal Melanom Market: Segment Outlook The global uveal melanoma market can be segmented based on diagnostic tests, therapy type, location type and geography. Location type can be further classified as iris melanoma, choroid melanoma and ciliary melanoma. Primary treatment involves enucleation i.e. removal of the affected eye. However this has now been replaced by radiation therapies such as plaque brachytherapy in the developed countries. Other types of treatment include external beam proton therapy, transpupillary thermotherapy, surgical resection techniques (transretinal endoresection and trans-scleral partial choroidectomy), gamma knife stereotactic surgery and also combination of these modalities. For small size tumors, the treatment available includes photocoagulation, photodynamic therapy, and local resection. The selection of appropriate treatment largely depends on the size and location of the tumor; associated ocular findings; the status of the fellow eye; and individual factors, including age, life expectancy, quality of life issues, concurrent systemic diseases and patient expectations.
Seite 1 / 2